GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 726 filers reported holding GLAXOSMITHKLINE PLC in Q4 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $328,000 | -10.4% | 7,569 | -16.1% | 0.24% | +2.5% |
| Q1 2016 | $366,000 | -0.5% | 9,017 | -1.2% | 0.24% | -3.2% |
| Q4 2015 | $368,000 | -20.3% | 9,129 | -24.0% | 0.25% | -29.2% |
| Q3 2015 | $462,000 | -10.3% | 12,004 | -2.8% | 0.35% | -4.1% |
| Q2 2015 | $515,000 | -12.3% | 12,354 | -2.9% | 0.36% | -10.3% |
| Q1 2015 | $587,000 | +5.6% | 12,728 | -2.1% | 0.41% | +2.5% |
| Q4 2014 | $556,000 | -23.2% | 12,998 | -17.4% | 0.40% | -28.8% |
| Q3 2014 | $724,000 | -19.0% | 15,744 | -5.8% | 0.56% | -18.8% |
| Q2 2014 | $894,000 | +44.9% | 16,712 | +27.0% | 0.68% | +23.4% |
| Q1 2014 | $617,000 | -15.5% | 13,158 | -3.8% | 0.56% | -6.4% |
| Q4 2013 | $730,000 | +7.0% | 13,677 | +0.5% | 0.59% | -0.2% |
| Q3 2013 | $682,000 | -2.6% | 13,603 | -3.0% | 0.59% | +14.7% |
| Q2 2013 | $700,000 | – | 14,018 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |